Page last updated: 2024-10-20

phosphorylethanolamine and Cancer of Pancreas

phosphorylethanolamine has been researched along with Cancer of Pancreas in 1 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Research Excerpts

ExcerptRelevanceReference
"Both breast and pancreatic cancer cells showed higher PE compared with their nonmalignant counterparts."1.48Molecular causes of elevated phosphoethanolamine in breast and pancreatic cancer cells. ( Bhujwalla, ZM; Glunde, K; Krishnamachary, B; Shah, T; Wijnen, JP; Wildes, F, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shah, T1
Krishnamachary, B1
Wildes, F1
Wijnen, JP1
Glunde, K1
Bhujwalla, ZM1

Other Studies

1 other study available for phosphorylethanolamine and Cancer of Pancreas

ArticleYear
Molecular causes of elevated phosphoethanolamine in breast and pancreatic cancer cells.
    NMR in biomedicine, 2018, Volume: 31, Issue:8

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Down-Regulation; Epithelial Cells; Ethan

2018